Skip to main content

Table 2 Direct comparison and homogeneity test among interventions

From: Comparative effectiveness of seven interventions for chronic hepatitis D: a systematic review and network meta-analysis of randomized controlled trials

Intervertion

Virological response (EOF)

Virological response (FU24W)

Biochemical response (EOF)

Biochemical response (FU24W)

Histological response

RR

(95% CI)

HM

RR

(95% CI)

HM

RR

(95% CI)

HM

RR

(95% CI)

HM

RR

(95% CI)

HM

I2 (%)

p-value

I2 (%)

p-value

I2 (%)

p-value

I2 (%)

p-value

I2 (%)

p-value

A

vs

B

0.37

(0.09, 1.56)

-

-

0.27

(0.04, 2.07)

-

-

1.48

(0.66, 3.33)

-

-

0.71

(0.20, 2.53)

-

-

1.00

(0.38, 2.61)

-

-

A

vs

C

0.26

(0.07, 0.98)

-

-

0.30

(0.04, 2.12)

-

-

1.69

(0.90, 3.17)

-

-

0.65

(0.22, 1.95)

-

-

1.55

(0.48, 4.93)

-

-

A

vs

D

1.00

(0.16, 6.3)

-

-

2.20

(0.10, 49.06)

-

-

2.01

(0.76, 5.35)

-

-

2.06

(0.25, 17.34)

-

-

3.75

(0.25, 57.45)

-

-

B

vs

C

0.71

(0.37, 1.36)

-

-

1.11

(0.46, 2.71)

-

-

1.14

(0.51, 2.56)

-

-

0.91

(0.39, 2.14)

-

-

1.55

(0.56, 4.29)

-

-

B

vs

D

2.71

(0.64, 11.4)

-

-

6.05

(0.37, 99.49)

-

-

1.36

(0.45, 4.09)

-

-

2.90

(0.39, 21.7)

-

-

3.70

(0.25, 54.07)

-

-

B

vs

F

10.88

(1.57, 75.48)

-

-

3.89

(0.23, 66.95)

-

-

4.62

(1.18, 18.05)

-

-

-

-

-

-

1.04

(0.15, 7.10)

-

-

C

vs

D

3.84

(1.02, 14.41)

-

-

5.30

(0.34, 82.77)

-

-

1.19

(0.45, 3.15)

-

-

3.17

(0.47, 21.43)

-

-

2.50

(0.16, 39.05)

-

-

D

vs

E

0.93

(0.67, 1.28)

0.00

0.83

0.99

(0.70, 1.39)

0.00

0.96

0.95

(0.70, 1.29)

0.00

0.94

0.93

(0.67, 1.28)

0.00

0.57

0.88

(0.56, 1.37)

0.00

0.95

D

vs

F

7.28

(1.47, 35.99)

0.21

0.26

12.25

(2.39, 62.81)

0.33

0.22

2.99

(1.14, 7.88)

0.00

0.76

2.64

(1.14, 6.12)

0.00

0.42

1.05

(0.36, 3.07)

0.00

0.77

D

vs

G

2.55

(1.38, 4.73)

0.21

0.28

1.93

(0.61, 6.17)

0.00

0.38

6.09

(1.92, 19.33)

0.00

0.94

5.73

(0.90, 36.5)

0.00

0.75

1.39

(0.77, 2.52)

0.00

0.97

E

vs

F

6.11

(1.45, 25.7)

0.01

0.32

1.93

(0.61, 6.17)

0.00

0.38

3.14

(1.27, 7.8)

0.00

0.67

1.87

(0.79, 4.46)

0.35

0.22

1.65

(0.86, 3.16)

0.00

0.64

  1. A: Bulevirtide, B: Bulevirtide + NAs, C: Bulevirtide + IFNα, D: IFNα, E: IFNα + NAs, F: NAs, G: No treatment
  2. HM Heterogeneity measures